{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:51:05Z","timestamp":1793303465282,"version":"4.5.0"},"reference-count":57,"publisher":"Informa UK Limited","issue":"2","funder":[{"name":"AIRC","award":["ID. 20160"],"award-info":[{"award-number":["ID. 20160"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1080\/13543776.2025.2606811","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:20:04Z","timestamp":1766049604000},"page":"145-157","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["The future of BRD9 inhibitors: a patent perspective (2019-present)"],"prefix":"10.1080","volume":"36","author":[{"given":"Eleonora","family":"Boccia","sequence":"first","affiliation":[{"name":"University of Salerno","place":["Fisciano, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Terracciano","sequence":"additional","affiliation":[{"name":"University of Salerno","place":["Fisciano, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Chini","sequence":"additional","affiliation":[{"name":"University of Molise","place":["Pesche, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bifulco","sequence":"additional","affiliation":[{"name":"University of Salerno","place":["Fisciano, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Lauro","sequence":"additional","affiliation":[{"name":"University of Salerno","place":["Fisciano, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90191-E"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4286"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24020995"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2015.08.004"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.143"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210618"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.2741\/A663"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3256"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17111849"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28073043"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17030392"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S286867"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002008"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.09.032"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0221-1"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123428"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00422-1"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2010.10.004"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.01.007"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.6.23.4996"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1096502"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111634"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2017-0243"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c00883"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00256"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00371-6"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2022.100297"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.05.063"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16443-x"},{"key":"e_1_3_4_32_1","unstructured":"Foghorn Therapeutics Inc. Compounds and uses thereof. WO2021022163A2. 2019."},{"key":"e_1_3_4_33_1","unstructured":"Novartis AG. BRD9 bifunctional degraders and their methods of use. WO2021055295A1. 2019."},{"key":"e_1_3_4_34_1","unstructured":"C4 Therapeutics Inc. Compounds for targeted degradation of BRD9. WO2021178920A1. 2020."},{"key":"e_1_3_4_35_1","unstructured":"Rumi Scientific Holdings I. Use of bromodomain inhibitors for treatment of Huntington\u2019s disease. WO2021207387A1. 2020."},{"key":"e_1_3_4_36_1","unstructured":"Foghorn Therapeutics Inc. Citrate salt pharmaceutical compositions and methods of making and using the same. WO2023283263A1. 2021."},{"key":"e_1_3_4_37_1","unstructured":"C4 Therapeutics Inc. Selected compounds for targeted degradation of BRD9. WO2023039208A1. 2021."},{"key":"e_1_3_4_38_1","unstructured":"The University of Chicago. Use of bromodomain-containing protein 9 inhibitors to treat and\/or prevent uterine leiomyosarcoma. US20240000787A1. 2022."},{"key":"e_1_3_4_39_1","unstructured":"Foghorn Therapeutics Inc. Therapeutic regimens of a degrader of BRD9. WO2023009701. 2022."},{"key":"e_1_3_4_40_1","unstructured":"Foghorn Therapeutics Inc. Methods of treating cancer. WO2025015149A2. 2023."},{"key":"e_1_3_4_41_1","unstructured":"Foghorn Therapeutics Inc. Methods of treating hematologic cancer. WO2025015152A1. 2023."},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2010.00184.x"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60111-1"},{"key":"e_1_3_4_44_1","unstructured":"MedlinePlus. Huntington\u2019s disease - genetics. National Library of Medicine; 2020 Available from: https:\/\/medlineplus.gov\/genetics\/condition\/huntingtons-disease\/"},{"key":"e_1_3_4_45_1","unstructured":"Gmbh Boehrigner Ingelheims Int. New pyridinones and isoquinolinones as inhibitors of the bromodomain BRD9. WO2016139361A1. 2015."},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11142160"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02004-x"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2025.104376"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19648-w"},{"key":"e_1_3_4_50_1","unstructured":"Foghorn Therapeutics Inc. Compounds and uses thereof. WO2020160192A1 WO2020160193A2 WO2020160196A1 WO2020160198A1. 2019."},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189215"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.41305"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2014.08.012"},{"key":"e_1_3_4_54_1","unstructured":"Biopharma PEG. PROTAC degraders in clinical trails: 2025 update. 2025. Available from: http:\/\/www.zpeg.net\/434.html"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-2583"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.7b00549"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-174555"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.20"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2007.06.001"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2025.2606811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T11:33:10Z","timestamp":1770031990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2025.2606811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1080\/13543776.2025.2606811"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2025.2606811","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-07-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}